EL

Earendil Labs at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Earendil Labs brings 5 presentations to ENA 2026 in Barcelona. Its posters centre on bispecific and biparatopic antibody-drug conjugates, several designed with AI guidance. Targets include the pairs Nectin-4/HER2, EGFR and FGFR2b, and TROP2/PD-L1, plus B7H3 and DLL3, with the Nectin-4/HER2 conjugate carrying a topoisomerase I inhibitor payload.

OrganizationENA 2026 Attendance
EL
Earendil Labs
Biotech
AI-driven biologics developer building bispecific and multispecific antibodies and antibody-drug conjugates.
Poster
Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm
Poster
Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm
Poster
Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Earendil Labs

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction